eIF4G1 interactions have been targeted by translation inhibitor 4EGI-1 to reduce eIF4G1-eIF4E interaction in human melanoma and breast cancer cell lines, showing anti-neoplastic activity, which was also confirmed in mice xenograft models [137]. This evidence concerns the gene EIF4G1 and breast carcinoma.